Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/day.
Lemez
P
P
D000328:Adult; D001772:Blood Cell Count; D002118:Calcium / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood / Q000188:drug therapy*; D012016:Reference Values; D014212:Tretinoin / Q000009:adverse effects* / Q000627:therapeutic use
D014212:Tretinoin; D002118:Calcium